
CellFE
Company developing a microfluidics based device to deliver gene-editing molecules.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
* | $22.0m | Series A | |
Total Funding | 000k |
Related Content
CellFE is a biotechnology company focused on advancing cell therapies through innovative microfluidic cellular engineering technology. The company serves advanced cell therapy researchers and developers, operating in the biotechnology and healthcare markets. CellFE's business model revolves around providing cutting-edge solutions that enhance the manufacturing process of cell therapies, making them more potent, durable, and cost-effective. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary technology. The company is dedicated to supporting cell therapy innovators in producing superior treatments for patients worldwide, leveraging a team of seasoned biotech experts and inventors.
Keywords: microfluidic technology, cell therapy, biotechnology, healthcare, manufacturing, cost-effective, potent treatments, durable therapies, partnerships, licensing.